News Sections
$100M Expansion Of Pharmaceutical Operations In Bloomington
Updated January 8, 2019 6:56 AM | Filed under: Business
 Print    Archive    RSS

(BLOOMINGTON) - A company is moving forward on a $100 million expansion of its pharmaceutical manufacturing operations in southern Indiana.

The state of Indiana and the city of Bloomington announced Monday that Somerset, New Jersey-based Catalent Inc. plans a "significant expansion" of its manufacturing of biologics, which are drugs made from living cells instead of chemicals. The expansion in Bloomington includes creating up to 200 new jobs by the end of 2024.

The maker of drug delivery technologies is working to expand drug substance manufacturing capacity and other capacities due to projected growth.

Catalent already employs about 900 people in Bloomington.

The Indiana Economic Development Corp. has offered Catalent up to $2.4 million in conditional tax credits based on the company's job creation plans. The city of Bloomington is considering additional incentives.

« Previous Article
Next Article »

 Print    Archive    RSS

Have a question or comment about a news story? Send it to

Advertise with 1340 AM WBIW
Find more about Weather in Bedford, IN
Advertise with 1340 AM WBIW

1340 AM WBIW, Bedford's Place To Talk. Serving Lawrence and surrounding counties since 1948!

© 2019 Ad-Venture Media, Inc. All Rights Reserved. and Listen Live Powered by HPC

Advertise  |  Careers  |  Contests  |  About  |  Feedback  |  Public File